Please assess the completion status of the following clinical trial:

Trial Title: Gabapentin vs Chlordiazepoxide for Ambulatory Alcohol Withdrawal

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Alcohol dependent at risk for withdrawal symptoms~Exclusion Criteria:~* Benzodiazepine dependent

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- Chlordiazepoxide (Type: ACTIVE_COMPARATOR): Chlordiazepoxide 25mg capsule or matching placebo capsule
- Gabapentin (Type: EXPERIMENTAL): Gabapentin 300mg capsule or matching placebo capsule

Based on this trial design, predict the completion outcome and termination type (if applicable).